Galecto, Inc. (GLTO)
NASDAQ: GLTO · Real-Time Price · USD
28.15
-1.91 (-6.34%)
At close: Mar 3, 2026, 4:00 PM EST
28.08
-0.07 (-0.23%)
After-hours: Mar 3, 2026, 4:00 PM EST
Galecto Market Cap
Galecto has a market cap or net worth of $1.7 billion as of March 3, 2026. Its market cap has increased by 28,008.59% in one year.
Market Cap
1.70B
Enterprise Value
1.77B
1-Year Change
28,008.59%
Ranking
Category
Stock Price
$28.15
Market Cap Chart
Since the IPO on October 29, 2020, Galecto's market cap has increased from $368.78M to $1.70B, an increase of 359.75%. That is a compound annual growth rate of 33.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 1.81B | 4,825.17% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.84B |
| Relay Therapeutics | 1.83B |
| Palvella Therapeutics | 1.81B |
| Vericel | 1.81B |
| RAPT Therapeutics | 1.79B |
| Tyra Biosciences | 1.78B |
| Agios Pharmaceuticals | 1.77B |
| Enliven Therapeutics | 1.76B |